Neuralink Overview

  • Founded
  • 2016

Founded
  • Status
  • Private

  • Employees
  • 420

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 23

Neuralink General Information

Description

Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is designed to treat and diagnose neurological conditions in humans and conceivably augment human cognitive powers, enabling doctors to treat serious brain diseases in the short term.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 7400 Paseo Padre Parkway
  • Fremont, CA 94555
  • United States
+1 (650) 000-0000

Neuralink Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuralink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 22-Sep-2022 00000 Completed Generating Revenue
6. Secondary Transaction - Private 07-Dec-2021 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 30-Jul-2021 00000 00000 00.00 Completed Generating Revenue
4. Early Stage VC (Series B) 28-Jun-2019 0000 00000 00000 Completed Generating Revenue
3. Accelerator/Incubator 09-Apr-2019 00000 Completed Generating Revenue
2. Early Stage VC 15-May-2018 $107M Completed Generating Revenue
1. Early Stage VC 24-Aug-2017 $107M $107M 00000 Completed Generating Revenue
To view Neuralink’s complete valuation and funding history, request access »

Neuralink Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series B-1 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 13,391,700 $0.001000 $0.19 $3.82 $3.82 1x $3.82 8.74%
Series A 107,000,000 $0.001000 $0.05 $1 $1 1x $1 69.84%
To view Neuralink’s complete cap table history, request access »

Neuralink Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is d
Therapeutic Devices
Fremont, CA
420 As of 2023
00000
0000000000 0 00000

000000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
0000000000 000000000
Los Angeles, CA
00 As of 0000
000.00
000000000 000.00

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
00000 0000000000 000
Providence, RI
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuralink Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kernel Venture Capital-Backed Los Angeles, CA 00 000.00 000000000 000.00
000000000 Venture Capital-Backed Providence, RI 00000000000
00000000000 Venture Capital-Backed Austin, TX 00 000.00 000000000 000.00
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
00000000 Formerly VC-backed Pompano Beach, FL 000 0000 0000000000. 0000
You’re viewing 5 of 8 competitors. Get the full list »

Neuralink Patents

Neuralink Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3996802-A1 Sandwich assembly scheme for thin film electrode array and integrated circuits Pending 12-Jul-2019 000000000
US-20210008364-A1 Sandwich assembly scheme for thin film electrode array and integrated circuits on both sides of printed circuit board (pcb) and method of manufacture Active 12-Jul-2019 000000000
US-11444056-B2 Sandwich assembly scheme for thin film electrode array and integrated circuits on both sides of printed circuit board (pcb) and method of manufacture Active 12-Jul-2019 000000000 00
EP-3997045-A4 Monolithic, biocompatible feedthrough for hermetically sealed electronics and methods of manufacture Pending 12-Jul-2019 00000000 0
US-11446084-B2 Laser drilling of pia mater Active 12-Jul-2019 A61B18/20 00
To view Neuralink’s complete patent history, request access »

Neuralink Executive Team (11)

Name Title Board Seat Contact Info
Shivon Zilis Director of Operations and Special Projects
Dongjin Seo Co-Founder & Vice President of Brain Interfaces and Implant
Elon Musk Co-Founder & Co-Chief Executive Officer
Jared Birchall Co-Chief Executive Officer & Board Member
You’re viewing 4 of 11 executive team members. Get the full list »

Neuralink Board Members (1)

Name Representing Role Since
Jared Birchall Self Co-Chief Executive Officer & Board Member 000 0000
To view Neuralink’s complete board members history, request access »

Neuralink Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuralink Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Pre IPO Club Venture Capital Minority 000 0000 000000 0
Raison VC-Backed Company Minority 000 0000 000000 0
Alphabet Holding Company Minority 000 0000 000000 0
Blake Byers Angel (individual) Minority 000 0000 000000 0
EXOR Seeds Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 23 investors. Get the full list »